MET Amplification and Exon 14 Splice Site Mutation Define Unique Molecular Subgroups of Non-Small Cell Lung Carcinoma with Poor Prognosis
Publication in refereed journal


Times Cited
Web of Science124WOS source URL (as at 17/09/2020) Click here for the latest count
Altmetrics Information
.

Other information
AbstractPurpose: Activation of MET oncogene as the result of amplification or activation mutation represents an emerging molecular target for cancer treatment. We comprehensively studied MET alterations and the clinicopathologic correlations in a large cohort of treatment-naive non-small cell lung carcinoma (NSCLC).
All Author(s) ListTong JH, Yeung SF, Chan AWH, Chung LY, Chau SL, Lung RWM, Tong CY, Chow C, Tin EKY, Yu YH, Li H, Pan Y, Chak WP, Ng CSH, Mok TSK, To KF
Journal nameClinical Cancer Research
Year2016
Month6
Day15
Volume Number22
Issue Number12
PublisherAMER ASSOC CANCER RESEARCH
Pages3048 - 3056
ISSN1078-0432
eISSN1557-3265
LanguagesEnglish-United Kingdom
Web of Science Subject CategoriesOncology

Last updated on 2020-18-09 at 01:17